Crinetics Pharmaceuticals' IPO

Crinetics Pharmaceuticals raised a round of funding on July 18, 2018. Investors include Public.

Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of specialty endocrine disorders in neuroendocrinology, reproductive medicine,…

Articles about Crinetics Pharmaceuticals' IPO: